Epizyme, Inc. (EPZM): Price and Financial Metrics
Epizyme, Inc. (EPZM)
Today's Latest Price: $25.48 USD
0.30 (1.19%)
Updated Feb 20 5:21pm
Add EPZM to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
EPZM Stock Summary
- EPZM's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 5,880.93 -- higher than 99.17% of US-listed equities with positive expected earnings growth.
- With a price/sales ratio of 81.54, Epizyme Inc has a higher such ratio than 97.35% of stocks in our set.
- With a year-over-year growth in debt of 14,605.8%, Epizyme Inc's debt growth rate surpasses 99.51% of about US stocks.
- If you're looking for stocks that are quantitatively similar to Epizyme Inc, a group of peers worth examining would be MESO, NOVN, CUE, BLCM, and RARE.
- Visit EPZM's SEC page to see the company's official filings. To visit the company's web site, go to www.epizyme.com.
EPZM Daily Price Range
EPZM 52-Week Price Range
EPZM Stock Price Chart More Charts
EPZM Price/Volume Stats
| Current price | $25.48 | 52-week high | $27.82 |
| Prev. close | $25.18 | 52-week low | $9.73 |
| Day low | $24.26 | Volume | 577,700 |
| Day high | $25.60 | Avg. volume | 1,158,444 |
| 50-day MA | $22.50 | Dividend yield | N/A |
| 200-day MA | $15.26 | Market Cap | 2.32B |
Epizyme, Inc. (EPZM) Company Bio
Epizyme, Inc. discovers and develops epigenetic therapies for cancer patients. The company was founded in 2007 and is based in Cambridge, Massachusetts.
Top Stories View All
Best & Worst Performing Stock Industries for February 20, 2020
Best & Worst Performing Small Cap Stocks for February 20, 2020
Best & Worst Performing Mid Cap Stocks for February 20, 2020
Best & Worst Performing Large Cap Stocks for February 20, 2020
Best & Worst Performing Mega Cap Stocks for February 20, 2020
View All Top Stories
Loading social stream, please wait...